The transcriptomic technologies market was estimated to be worth USD 7.4 billion globally in 2024 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.2% over the course of the forecast period. The study of the transcriptome, or the entire collection of RNA transcripts generated by the genome in a given cell or under particular conditions, is known as transcriptomics.

It is propelled by advances in precision medicine, drug development, and RNA sequencing. Advances in RNA sequencing, especially single-cell and next-generation RNA sequencing, have greatly improved the capacity to more accurately examine gene expression. The need for sophisticated gene expression analysis has increased due to the rise in hereditary abnormalities and chronic diseases like diabetes, cancer, and cardiovascular ailments.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/transcriptomics-technologies-market

Growth Drivers

The industry is expanding at a substantial rate thanks to rising investments in genetic research. The demand in this field is increasing as a result of government funding and initiatives for genomic research, as well as strategic alliances between biopharmaceutical companies, research institutions, and technology providers. These alliances are encouraging cooperative efforts that expedite the research and development process. Research efforts have been strengthened by the growing emphasis on comprehending disease mechanisms at the transcriptome level, which has attracted both governmental and private support.

pharmacological development frequently uses transcriptomics technologies to determine pharmacological targets, comprehend mechanisms of action, and evaluate the effectiveness of medications. Collaborations between academic institutions and business titans are greatly supporting market expansion. Single-cell RNA sequencing is anticipated to spur investment and innovation in the global transcriptomics market due to technical advancements.

Segmentation

By Type

·         Consumables

·         Instruments

·         Software

·         Services

By Technologies

·         Micro Array

·         q PCR

·         Sequencing Technology

By Application

·         Drug Discovery

·         Diagnostics and Disease Profiling

·         Others

By Region

·         Asia Pacific

·         North America

·         Latin America

·         Middle East and Africa

·         Europe

Key Players

·         Danaher Corp.

·         Affymetrix Inc.

·         Bio-Rad Laboratories, Inc.

·         Promega Corporation

·         Merck and Company Inc.

·         Fluidigm Corporation

·         LC Sciences

·         F. Hoffmann-La Roche Ltd.

·         Life Technologies Corporation

·         Illumina

·         Thermo Fisher Scientific

·         Agilent Technologies

·         Qiagen N.V.

·         Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/transcriptomics-technologies-market

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/